New reports detail sustained HIV remission following stem cell transplantation approaches, including cases without classic CCR5Δ32 homozygosity. Researchers described durable viral control after transplant and immune reconstitution in patients who stopped antiretroviral therapy, suggesting alternative mechanisms beyond the well‑known CCR5Δ32 knockout may enable remission. These studies, published in high‑profile outlets, characterize immune repertoires and stem cell grafts that contributed to viral suppression. Authors emphasize the rarity of the outcomes and the complexity of translating transplant‑level interventions to broader populations. The findings revive interest in curative strategies and immunologic correlates, but investigators note scalability, safety and ethical considerations will limit clinical adoption outside specialized settings.